Pharmaron Beijing (03759): nominates Zeng Jinfeng as a candidate for the supplementary election of independent non-executive directors.
Kanglong Chemical Co. (03759) announced that Mr. Zeng Kunhong has voluntarily resigned from his position as an independent non-executive director of the third board of directors.
Pharmaron Beijing (03759) announced that Mr. Zeng Kunhong has voluntarily resigned from his position as an independent non-executive director of the third board of directors, as well as from the positions of the board's audit committee, compensation and assessment committee, and nomination committee. On October 28, 2025, the board of directors deliberated and passed a resolution to nominate Professor Zeng Jinfeng as a candidate for the by-election of an independent non-executive director of the third board of directors. Pending Professor Zeng's appointment at the extraordinary general meeting of shareholders, the board of directors has approved the election of Professor Zeng to serve as a member of the board's audit committee, compensation and assessment committee, and nomination committee.
Related Articles

US Stock Market Move | Nucor Corporation (NUE.US) rose by more than 5.6% with Q3 net profit doubling year-on-year.

US Stock Market Move | Planned issuance of $1 billion in convertible senior notes Galaxy Digital (GLXY.US) plummeted by over 8%.

US Stock Market Move | Intel Corporation (INTC.US) rose more than 6%. The CEO said the company will focus on AI and contract manufacturing business.
US Stock Market Move | Nucor Corporation (NUE.US) rose by more than 5.6% with Q3 net profit doubling year-on-year.

US Stock Market Move | Planned issuance of $1 billion in convertible senior notes Galaxy Digital (GLXY.US) plummeted by over 8%.

US Stock Market Move | Intel Corporation (INTC.US) rose more than 6%. The CEO said the company will focus on AI and contract manufacturing business.

RECOMMEND

Why European Automakers Are Opposing Dutch Sanctions
20/10/2025

Domestic Commercial Rockets Enter Batch Launch Era: Behind the Scenes a Sixfold Cost Gap and Reusability as the Key Breakthrough
20/10/2025

Multiple Positive Catalysts Lift Tech Stocks; UBS Elevates China Tech to Most Attractive, Citing AI as Core Rationale
20/10/2025


